Metastatic neuroendocrine neoplasia treatments in patients over 70 years of age

The incidence of neuroendocrine neoplasia (NEN) is higher in individuals ≥70 years of age (elderly) who are underrepresented in clinical trials because of comorbidities and low performance status. We retrospectively analyzed the outcome of elderly patients with metastatic NEN (mNEN). Comorbidities w...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Endocr Connect
Hlavní autoři: Bongiovanni, Alberto, Recine, Federica, Foca, Flavia, Fausti, Valentina, Riva, Nada, Fabbri, Greta, Severi, Stefano, Liverani, Chiara, De Vita, Alessandro, Spadazzi, Chiara, Miserocchi, Giacomo, Mercatali, Laura, Amadori, Dino, Ibrahim, Toni
Médium: Artigo
Jazyk:Inglês
Vydáno: Bioscientifica Ltd 2018
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6311458/
https://ncbi.nlm.nih.gov/pubmed/30530877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-18-0478
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky